SeedToB Capital
VC Fund
Suwanee, United States
SeedToB Capital is a VC fund in Suwanee focused on Health Care and Medical. SeedToB Capital primarily focuses on artificial intelligence initiatives within healthcare. Most applications of AI in healthcare have results in pilot and early adaptor settings but don’t maximize their full potential of value despite huge investments. seedToB’s unique approach is to help entrepreneurs navigate this complex space towards mostefficient path to Series B. It is led by serial entrepreneurs who in their last startup founded Jvion and grew it to be the Nation’s largest clinical AI company which was sold at nine figure valuation in a all cash transaction.
- Total investments:
- 29
- Last investment:
- Lead investor:
- 55%
Last updated:
For AI agents: llms.txt
Industries SeedToB Capital invests in
Stages SeedToB Capital invests in
Countries SeedToB Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Shantanu Nigam
|
|||
Ritesh Sharma
|
|||
Investment Focus
Industry
- Health Care 11 (38%)
- Medical 4 (14%)
- Wellness 4 (14%)
- Biotechnology 4 (14%)
- Health Diagnostics 4 (14%)
Stage
- Seed 9 (31%)
- Series A 7 (24%)
- Pre-Seed 3 (10%)
- Funding Round 3 (10%)
- Series B 2 (7%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Shantanu Nigam
Managing Partner
|
Managing Partner | Total investments: 8 | Find email | |
|
Ritesh Sharma
Managing Partner
|
Managing Partner | Total investments: 6 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
PALOL
|
Palol transforms complex B2B SaaS deployments into seamless, guided journeys. Our AI concierge personalizes every step of post-sale integration, getting your customers to value faster than ever. | $500K / Series A / Mar 01, 2026 | |
JOLISS
|
JOLISS autonomously discovers, maps, and risk scores undocumented APIs across your enterprise, delivering a unified risk portrait so you can act before vulnerabilities materialize. | $700K / Series A / Jan 01, 2026 | |
Interactly.ai
|
AI collaborators for all patient interactions, including fax, email, text, and voice | Pre-Seed / Jun 03, 2025 | |
Canid
|
Candid simplifies pediatricians’ work by redesigning how the vaccination process works. The company's scanning system eliminates the need for manual data entry and uploads vaccine information into state registries. | $10M / Series A / Jun 03, 2025 | |
SKRIBER
|
Skriber is a medical transcription and summarization SaaS company. Our platform uses advanced AI to automate the documentation process for healthcare providers, reducing the time spent on paperwork and improving accuracy. | $1.3M / Pre-Seed / May 20, 2025 | |
OncoLens
|
OncoLens develops technologies that improve cancer treatment planning, simplify tumor board management, facilitate survivorship care planning, and automate accreditation and quality reporting through an intelligent workflow engine that streamlines business processes and enables more informed clinical decision-making. | $16M / Series B / Oct 24, 2024 | |
Feel Therapeutics
|
Feel Therapeutics is a digital precision medicine company delivering objective data and passive measurement for mental health. The company develops physiological and digital biomarkers and therapeutics for mental health. Its Feel data monitoring device leverages five embedded sensors via the wristband. Feel collects biometric data and analyzes themusing the latest cutting-edge methods of computer science to develop digital biomarkers.Feel Therapeutics, formerly known as Sentio Solutions. | $830K / Convertible Note / Apr 10, 2024 | |
Shimmer
|
Shimmer provides a platform for 1:1 remote ADHD coaching. Our platform matches users to an ADHD coach who helps guide them towards identifying and meeting goals, maintaining a positive approach to change, and improving productivity while providing a source of accountability. | $2.2M / Seed / Jan 10, 2024 | |
|
Feel Therapeutics
|
Feel Therapeutics is a digital precision medicine company delivering objective data and passive measurement for mental health. The company develops physiological and digital biomarkers and therapeutics for mental health. Its Feel data monitoring device leverages five embedded sensors via the wristband. Feel collects biometric data and analyzes themusing the latest cutting-edge methods of computer science to develop digital biomarkers.Feel Therapeutics, formerly known as Sentio Solutions. | Jan 09, 2024 | |
|
Canid
|
Candid simplifies pediatricians’ work by redesigning how the vaccination process works. The company's scanning system eliminates the need for manual data entry and uploads vaccine information into state registries. | $1.5M / Sep 21, 2023 | |
| See all 29 investments → | |||
Co-Investors
Alumni Ventures
4 deals together
Gaingels
4 deals together
Anthemis Exponential Ventures
3 deals together
SOSV
3 deals together
BIP Capital
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does SeedToB Capital invest in?
SeedToB Capital invests primarily in Health Care, Medical and Wellness startups, most often at Seed and Series A stage. Most of the 29 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact SeedToB Capital?
Public channels for SeedToB Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at SeedToB Capital?
The team at SeedToB Capital includes Shantanu Nigam (Managing Partner) and Ritesh Sharma (Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
